The health and life sciences industry is undergoing a period of transformation. Changing demand patterns, rising input costs and an uncertain regulatory horizon have payors, insurers, providers and suppliers in a high-pressure search for new innovative models.
Learn more

The financial crisis brought systemic and cultural changes that have had lasting impacts on the private equity landscape. Deteriorating exit conditions led to a sharp decline in activity and drop in liquid assets, but renewed economic optimism has replenished funds.
Learn more